Corrigendum: Candidate biomarkers for the prediction and monitoring of partial remission in pediatric type 1 diabetes.

Autor: Gomez-Muñoz L; Immunology Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Perna-Barrull D; Immunology Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Caroz-Armayones JM; Department of Political and Social Sciences, Health Inequalities Research Group (GREDS-EMCONET), Pompeu Fabra University, Barcelona, Spain.; Johns Hopkins University-Pompeu Fabra University Public Policy Center, Barcelona, Spain., Murillo M; Pediatrics Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Rodriguez-Fernandez S; Immunology Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Valls A; Pediatrics Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Vazquez F; Endocrinology Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Perez J; Pediatric Endocrinology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Autonomous University of Barcelona, Sabadell, Spain., Corripio R; Pediatric Endocrinology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Autonomous University of Barcelona, Sabadell, Spain., Castaño L; Cruces University Hospital, Biocruces Bizkaia Research Institute, UPV/EHU, CIBERDEM, CIBERER, Endo-ERN, Bilbao, Spain., Bel J; Pediatrics Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain., Vives-Pi M; Immunology Department, Germans Trias i Pujol Research Institute and University Hospital, Autonomous University of Barcelona, Badalona, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jun 11; Vol. 15, pp. 1439643. Date of Electronic Publication: 2024 Jun 11 (Print Publication: 2024).

Targeting macrophages with phosphatidylserine-rich liposomes as a potential antigen-specific immunotherapy for type 1 diabetes.

Autor: Garcia-Loza I; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain; Neuromuscular Diseases Group, Sant Pau Biomedical Research Institute, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain., Perna-Barrull D; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Aguilera E; Endocrinology Dept, Germans Trias I Pujol University Hospital, Badalona, Spain., Almenara-Fuentes L; Ahead Therapeutics SL, Barcelona, Spain., Gomez-Muñoz L; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Greco D; Ahead Therapeutics SL, Barcelona, Spain., Vila M; Ahead Therapeutics SL, Barcelona, Spain., Salvado M; Ahead Therapeutics SL, Barcelona, Spain., Mancera-Arteu M; Ahead Therapeutics SL, Barcelona, Spain., Olszowy MW; Sartorius Stedim North America, Inc., Arvada, CO, United States., Petriz J; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain., Dalmases M; Ahead Therapeutics SL, Barcelona, Spain., Rodriguez-Vidal S; Ahead Therapeutics SL, Barcelona, Spain., Barneda-Zahonero B; Ahead Therapeutics SL, Barcelona, Spain., Vives-Pi M; Immunology Department, Germans Trias I Pujol Research Institute, Autonomous University of Barcelona, Badalona, Spain; Endocrinology Dept, Germans Trias I Pujol University Hospital, Badalona, Spain; Ahead Therapeutics SL, Barcelona, Spain. Electronic address: mvives@igtp.cat.

Publikováno v: Journal of autoimmunity [J Autoimmun] 2024 May; Vol. 145, pp. 103196. Date of Electronic Publication: 2024 Mar 08.

Immunoregulatory Biomarkers of the Remission Phase in Type 1 Diabetes: miR-30d-5p Modulates PD-1 Expression and Regulatory T Cell Expansion.

Autor: Gomez-Muñoz L; Immunology Department, Germans Trias i Pujol Research Institute (IGTP), Autonomous University of Barcelona, 08916 Badalona, Spain., Perna-Barrull D; Immunology Department, Germans Trias i Pujol Research Institute (IGTP), Autonomous University of Barcelona, 08916 Badalona, Spain., Murillo M; Pediatrics Department, Germans Trias i Pujol University Hospital (HGTiP), Autonomous University of Barcelona, 08916 Badalona, Spain., Armengol MP; Translational Genomic Platform, Germans Trias i Pujol Research Institute (IGTP), Autonomous University of Barcelona, 08916 Badalona, Spain., Alcalde M; Physics Department, Universitat Politècnica de Catalunya (UPC), 08034 Barcelona, Spain.; Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain., Catala M; Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford OX1 2JD, UK., Rodriguez-Fernandez S; Immunology Department, Germans Trias i Pujol Research Institute (IGTP), Autonomous University of Barcelona, 08916 Badalona, Spain., Sunye S; Comparative Medicine and Bioimage Centre of Catalonia (CMCiB), Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain., Valls A; Pediatrics Department, Germans Trias i Pujol University Hospital (HGTiP), Autonomous University of Barcelona, 08916 Badalona, Spain., Perez J; Pediatric Endocrinology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), Autonomous University of Barcelona, 08208 Sabadell, Spain., Corripio R; Pediatric Endocrinology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), Autonomous University of Barcelona, 08208 Sabadell, Spain., Vives-Pi M; Immunology Department, Germans Trias i Pujol Research Institute (IGTP), Autonomous University of Barcelona, 08916 Badalona, Spain.

Publikováno v: Non-coding RNA [Noncoding RNA] 2023 Feb 28; Vol. 9 (2). Date of Electronic Publication: 2023 Feb 28.

Immune System Remodelling by Prenatal Betamethasone: Effects on beta-Cells and Type 1 Diabetes

Autor: Perna-Barrull, D, Gieras, A, Rodriguez-Fernandez, S, Tolosa, E, Vives-Pi, M

Publikováno v: Frontiers in Endocrinology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Type 1 diabetes (T1D) is a multifactorial disease of unknown aetiology. Studies focusing on environment-related prenatal changes, which might have an influence on the development of T1D, are still missing. Drugs, such as betamethasone, are used durin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::9bb238c5c144676cde637a4d2d7e33a0
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=3376

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.